Forecast & Rating4 analysts currently cover Vanda Pharma, of which 3 give a positive rating. The average price target is $12.19, about 132.6% upside from the current price of $5.24. Coverage is limited, so the data is for reference only. Data as of Aug 10, 2026; this does not constitute investment advice.
Aug 10, 2026Price forecast
$12.19132.14%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met29.6%
Stock price$5.24
Avg. target$12.2
High target$20
Low target$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.